These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24472318)
1. Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells. Singh R; Sharma MC; Sarkar C; Singh M; Chauhan SS FEBS J; 2014 Mar; 281(6):1629-41. PubMed ID: 24472318 [TBL] [Abstract][Full Text] [Related]
2. Ets-1/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells. Shukla AA; Jain M; Chauhan SS FEBS J; 2010 Apr; 277(8):1861-75. PubMed ID: 20236318 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421 [TBL] [Abstract][Full Text] [Related]
6. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta. Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495 [TBL] [Abstract][Full Text] [Related]
9. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068 [TBL] [Abstract][Full Text] [Related]
10. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells. Liu S; Shi X; Bauer I; Günther J; Seyfert HM Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844 [TBL] [Abstract][Full Text] [Related]
11. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription. Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Heckman CA; Wheeler MA; Boxer LM Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-β and CCAAT/enhancer-binding homologous protein. Venza M; Visalli M; Alafaci C; Caffo M; Caruso G; Salpietro FM; Tomasello F; Teti D Neurosurgery; 2011 Sep; 69(3):713-21; discussion 721. PubMed ID: 21471847 [TBL] [Abstract][Full Text] [Related]
14. C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma. Liu X; Liu K; Qin J; Hao L; Li X; Liu Y; Zhang X; Liu X; Li P; Han S; Mao Z; Shen L Int J Cancer; 2015 Jun; 136(11):2524-34. PubMed ID: 25382637 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins. Klick DE; Shadley JD; Hines RN Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657 [TBL] [Abstract][Full Text] [Related]
17. C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. Gao H; Schwartz RC Mol Immunol; 2009 Dec; 47(2-3):390-7. PubMed ID: 19782405 [TBL] [Abstract][Full Text] [Related]
18. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene. van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008 [TBL] [Abstract][Full Text] [Related]
19. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806 [TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]